5% stakes
Squadron Capital Management
Institution
- 5% stake reports
- 25
- 5% stake stocks
- 13
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Traws Pharma TRAW08/14 | 0%0 sh | −6.4pp |
| Relmada Therapeutics RLMD08/14 | 7%7,350,000 sh | −2.9pp |
| NextCure NXTC08/14 | 1.6%64,464 sh | −8.3pp |
| Lipocine LPCN08/14 | 9.8%810,000 sh | +3.6pp |
| C4 Therapeutics CCCC08/14 | 6.9%7,600,000 sh | +1.9pp |
| Quince Therapeutics QNCX08/04 | 5.6%55,173 sh | First report |
| InMed Pharmaceuticals INM05/27 | 9.8%325,000 sh | First report |
| C4 Therapeutics CCCC05/19 | 5%5,550,000 sh | First report |
| Spruce Biosciences SPRB05/15 | 0.9%12,200 sh | −5.6pp |
| Lipocine LPCN05/15 | 6.2%450,000 sh | −3.3pp |
| Traws Pharma TRAW05/15 | 6.4%511,714 sh | −2.5pp |
| Scynexis SCYX04/08 | 9.6%7,608,695 sh | First report |
| Aprea Therapeutics APRE04/07 | 9.9%1,271,081 sh | First report |
| Zentalis Pharmaceuticals ZNTL03/03 | 5.1%3,676,900 sh | First report |
| Palisade Bio PALI02/17 | 3%4,500,000 sh | −5.5pp |
| NextCure NXTC02/17 | 9.9%271,127 sh | +3.4pp |
| Lipocine LPCN25/12/23 | 9%500,000 sh | First report |
| Pasithea Therapeutics KTTA25/12/05 | 9.9%2,252,930 sh | First report |
| Traws Pharma TRAW25/11/14 | 8.4%591,000 sh | +2.4pp |
| NextCure NXTC25/10/24 | 6.5%173,861 sh | First report |
